Evidence map›Paper›PMID 30439626›Full record

ArticleTranslational oncology2019

High Keratin 8/18 Ratio Predicts Aggressive Hepatocellular Cancer Phenotype.

Nicole Golob-Schwarzl, Kira Bettermann, Anita Kuldeep Mehta, Sonja M Kessler, Julia Unterluggauer, Stefanie Krassnig, Kensuke Kojima, Xintong Chen, Yujin Hoshida, Nabeel M Bardeesy and 18 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Translational oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Genome Editing and Fatty Liver.Advances in experimental medicine and biology · 2023
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors at 12 institutions in 4 countries.

Nicole Golob-SchwarzlInstitute of Pathology, Medical University of Graz, Graz, Austria; Center for Biomarker Research in Medicine, Graz, Austria.
Kira BettermannInstitute of Pathology, Medical University of Graz, Graz, Austria.
Anita Kuldeep MehtaInstitute of Pathology, Medical University of Graz, Graz, Austria; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.
Sonja M KesslerInstitute of Pathology, Medical University of Graz, Graz, Austria; Department of Pharmacy, Pharmaceutical Biology, Saarland University, Saarbrücken, Germany.
Julia UnterluggauerInstitute of Pathology, Medical University of Graz, Graz, Austria.
Stefanie KrassnigInstitute of Pathology, Medical University of Graz, Graz, Austria.
Kensuke KojimaLiver Tumor Translational Research Program, University of Texas Southwestern Medical Center, Dallas, USA.
Xintong ChenLiver Tumor Translational Research Program, University of Texas Southwestern Medical Center, Dallas, USA.
Yujin HoshidaLiver Tumor Translational Research Program, University of Texas Southwestern Medical Center, Dallas, USA.
Nabeel M BardeesyCenter for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Boston, USA.
Heimo MüllerInstitute of Pathology, Medical University of Graz, Graz, Austria.
Vendula SvendovaInstitute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, Austria.
Michael G SchimekInstitute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, Austria.
Clemens DiwokyInstitute of Medical Engineering, Graz University of Technology, Graz, Austria; Institute of Molecular Biosciences, University of Graz, Graz, Austria.
Alexandra LipfertInstitute of Medical Engineering, Graz University of Technology, Graz, Austria.
Vineet MahajanInstitute of Pathology, Medical University of Graz, Graz, Austria.
Cornelia StumptnerInstitute of Pathology, Medical University of Graz, Graz, Austria.
Andrea ThüringerInstitute of Pathology, Medical University of Graz, Graz, Austria.
Leopold F FröhlichInstitute of Pathology, Medical University of Graz, Graz, Austria; AG VABOS, Department of Cranio-Maxillofacial Surgery, Univerity of Muenster, Germany.
Tatjana StojakovicClinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz, Graz, Austria.
K P R NilssonDepartment of Chemistry, Linköping University, Linköping, Sweden.
Thomas KolbeBiomodels Austria (Biat), University of Veterinary Medicine Vienna, Vienna, Austria; Department IFA-Tulln, University for Natural Resources and Applied Life Sciences Vienna, Vienna, Austria.
Thomas RülickeInstitute of Laboratory Animal Science, University of Veterinary Medicine Vienna, Vienna, Austria.
Thomas M MaginInstitute of Biology, University of Leipzig, Leipzig, Germany.
Pavel StrnadDepartment of Internal Medicine III, University Hospital RWTH Aachen, Aachen, Germany.
Alexandra K KiemerCenter for Biomarker Research in Medicine, Graz, Austria.
Richard MorigglInstitute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, Vienna, Austria; Ludwig Bolzmann Institute of Cancer Research, Vienna, Austria; Medical University Vienna, Vienna, Austria.
Johannes HaybaeckInstitute of Pathology, Medical University of Graz, Graz, Austria; Department of Pathology, Medical Faculty, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany. Electronic address: Johannes.haybaeck@med.ovgu.de.
Medical University of Graz · ATThe University of Texas Southwestern Medical Center · USUniversity of Veterinary Medicine Vienna · ATBOKU University · ATCenter For Biomarker Research In Medicine · ATDana-Farber Cancer Institute · USGraz University of Technology · ATHarvard University · USLeipzig University · DELinköping University · SEOtto-von-Guericke-Universität Magdeburg · DERWTH Aachen University · DE

Funding

Molecular Prognostic Indicators in Liver Cirrhosis and CancerR01DK099558 · NIDDK · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HOSHIDA, YUJIN · 2013 to 2016
$2.6M
NIDDK NIH HHS R01 DK099558
6 · The paper itself

Abstract

BACKGROUND &

aimsSteatohepatitis (SH) and SH-associated hepatocellular carcinoma (HCC) are of considerable clinical significance. SH is morphologically characterized by steatosis, liver cell ballooning, cytoplasmic aggregates termed Mallory-Denk bodies (MDBs), inflammation, and fibrosis at late stage. Disturbance of the keratin cytoskeleton and aggregation of keratins (KRTs) are essential for MDB formation.

methodsWe analyzed livers of aged Krt18

resultsOur analysis of the genetic profile of Krt18

conclusionsWe can prove that intermediate filaments and their binding partners are tightly linked to hepatic lipid metabolism and to hepatocarcinogenesis. We suggest KRT8/18 ratio as a novel HCC biomarker for HCC.

Identifiers

PMID30439626
PMCPMC6234703
OpenAlexW2901630960

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.